← Back to Search

Loss-Framed Financial Incentives for Cardiovascular Disease (IMPACT-CR Trial)

N/A

Waitlist Available

Led By Srinath Adusumalli, MD, MS

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 12-week intervention period

Awards & highlights

IMPACT-CR Trial Summary

This trial will test whether adding a game element or financial incentive to cardiac rehab attendance will increase participation.

IMPACT-CR Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 12-week intervention period

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 12-week intervention period

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12-week intervention period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of cardiac rehabilitation sessions attended during intervention

Secondary outcome measures

Change in mean daily step counts from baseline to 12-week period

Proportion of patients that attend 30 of the 36 cardiac rehabilitation sessions during intervention

Other outcome measures

Proportion of days that wearable device was used

Proportion of participants that completed the entire study

Proportion of participants that identified a support partner

IMPACT-CR Trial Design

3Treatment groups

Experimental Treatment

Group I: Loss-Framed Financial Incentive InterventionExperimental Treatment1 Intervention

Participants are informed that each week that $14 is placed in a virtual account for them. Each day, the participant is informed of their step count on the prior day. If the step goal was achieved, the balance remains. Each day the goal is not achieved, the participant is informed that $2 was taken away.

Group II: Gamification and Loss-Framed Financial Incentive InterventionExperimental Treatment2 Interventions

Participants receive both of the interventions described in the Gamification Intervention arm and the Financial Incentive Intervention arm.

Group III: Gamification InterventionExperimental Treatment1 Intervention

Participants sign a pledge agreeing to try their best to meet their goals. Participants are entered into a game. Each week they receive 70 points. Each day, they are told their step count and points. If the step goal was met they keep their points, but if not, they lose 10 points. At the end of the week if they have at least 40 points they move up a level, but if not, they drop a level. Participants start in the middle of 5 levels. Participants choose a support partner who receives a weekly email with the participant's progress. The study group will hold a 3-way phone call with the participant and supportive sponsor to discuss ways they can help the participant meet their goal. At 6 weeks, the study group will have a follow up call if the participant is stuck in a lower level and restart them back at the middle level.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Gamification

2019

Completed Phase 3

~2230

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,000 Previous Clinical Trials

42,880,088 Total Patients Enrolled

National Institute on Aging (NIA)NIH

1,668 Previous Clinical Trials

28,005,064 Total Patients Enrolled

Srinath Adusumalli, MD, MSPrincipal InvestigatorUniversity of Pennsylvania

Media Library

Loss-Framed Financial Incentives Clinical Trial Eligibility Overview. Trial Name: NCT04304872 — N/A

Cardiovascular Disease Research Study Groups: Gamification Intervention, Gamification and Loss-Framed Financial Incentive Intervention, Loss-Framed Financial Incentive Intervention

Cardiovascular Disease Clinical Trial 2023: Loss-Framed Financial Incentives Highlights & Side Effects. Trial Name: NCT04304872 — N/A

Loss-Framed Financial Incentives 2023 Treatment Timeline for Medical Study. Trial Name: NCT04304872 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any participants being accepted into the trial at this time?

"Currently, this study is not actively seeking participants. As outlined on clinicaltrials.gov, the posting date was December 1st 2022 and it has been updated most recently on September 28th 2022. However, there are 415 other studies that still require patients to participate."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Improving Physical Activity and Cardiac Rehabilitation Attendance Using Technology and Behavioral Economics

2023. "Improving Physical Activity and Cardiac Rehabilitation Attendance Using Technology and Behavioral Economics". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04304872.